Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme

Applied Microbiology and Biotechnology

Volumn 86, Issue 5, 2010, Pages 1439-1449

  Son, Jee Soo ^a   Lee, Se Jung ^a   Jun, Soo Youn ^b   Yoon, Seong Jun ^b   Kang, Sang Hyeon ^b   Paik, Hyoung Rok ^b   Kang, Jung Ok ^b   Choi, Yun Jaie ^a  

^a Seoul National University   (South Korea)

^b INtRON Biotechnology Inc   (South Korea)

Author keywords

Bacteriophage; Biofilm; Cell wall degrading enzyme; Podoviridae; Staphylococcus aureus

Indexed keywords

BIOFILM CELLS; DEGRADING ENZYMES; LOW TEMPERATURES; METHICILLIN; MINIMUM INHIBITORY CONCENTRATION; PODOVIRIDAE; RECOMBINANT CELLS; REMOVAL ACTIVITY; RESISTANT STRAINS; S. AUREUS; STAPHYLOCOCCUS AUREUS;

BACTERIOPHAGES; BIOFILMS; BIOFILTERS; CELL CULTURE; CELLS; ESCHERICHIA COLI;

ENZYMES;

ANTIBIOTIC AGENT; SAL 2 ENZYME; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIOPHAGE; BACTERIUM; BIOFILM; ENZYME ACTIVITY; INHIBITOR; LOW TEMPERATURE; RECOMBINATION;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOLYSIS; BACTERIOPHAGE; BACTERIUM CULTURE; BIOFILM; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; GENETIC ANALYSIS; LOW TEMPERATURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOLYSIS; BIOFILMS; CATTLE; CELL WALL; ENDOPEPTIDASES; GENOME, VIRAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PODOVIRIDAE; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES;

ESCHERICHIA COLI; PODOVIRIDAE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 77952890163     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-009-2386-9     Document Type: Article

References (36)

1. HW Ackermann 1998 Tailed bacteriophage: the order Caudovirales Adv Virus Res 51 135 201 10.1016/S0065-3527(08)60785-X 1:STN:280:DyaK1M7gvVOgtA%3D%3D
2. E Ando K Monden R Mitsuhata R Kariyama H Kumon 2004 Biofilm formation among methicillin-resistant Staphylococcus aureus isolates from patients with urinary tract infection Acta Med Okayama 58 207 214 1:CAS:528: DC%2BD2cXnvVOqsr0%3D
3. JM Andrews 2001 Determination of minimum inhibitory concentrations J Antimicrob Chemother 48 Suppl 1 5 16 1:CAS:528:DC%2BD3MXlsVegtr8%3D
4. CR Arciola L Montanaro L Baldassarri E Borsetti D Cavedagna E Donati 1999 Slime production by Staphylococci isolated from prosthesis-associated infections New Microbiol 22 337 341 1:STN:280:DC%2BD3c%2Fit12jtg%3D%3D
5. J Azeredo IW Sutherland 2008 The use of phages for the removal of infectious biofilms Curr Pharm Biotechnol 9 261 266 10.2174/138920108785161604 1:CAS:528:DC%2BD1MXisFCksb4%3D
6. AC Baird-Parker 1962 An improved diagnostic and selective medium for isolating coagulase-positive staphylococci J Appl Bacteriol 25 12 19
7. AL Barry F García LD Thrupp 1970 An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens Am J Clin Pathol 53 149 158 1:CAS:528:DyaE3cXht12gs70%3D
8. LK Celia D Nelson DE Kerr 2008 Characterization of a bacteriophage lysin (Ply700) from Streptococcus uberis Vet Microbiol 130 107 117 10.1016/j.vetmic.2007.12.004 1:CAS:528:DC%2BD1cXntlGns78%3D
9. A Chokr D Leterme D Watier S Jabbouri 2007 Neither the presence of ica locus, nor in vitro-biofilm formation ability is a crucial parameter for some Staphylococcus epidermidis strains to maintain an infection in a guinea pig tissue cage model Microb Pathog 42 94 97 10.1016/j.micpath.2006.09.001 1:CAS:528:DC%2BD2sXit1Ggurw%3D (Pubitemid 46283319)
10. JW Costerton PS Stewart EP Greenberg 1999 Bacterial biofilms: a common cause of persistent infections Science 284 1318 1322 10.1126/science.284.5418. 1318 1:CAS:528:DyaK1MXjs1Squ78%3D (Pubitemid 29289651)
11. SE Cramton C Gerke NF Schnell WW Nichols F Götz 1999 The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation Infect Immun 67 5427 5433 1:CAS:528: DyaK1MXmsFWmsrc%3D
12. S Davison E Couture-Tosi T Candela M Mock A Fouet 2005 Identification of the Bacillus anthracis γ phage receptor J Bacteriol 187 6742 6749 10.1128/JB.187.19.6742-6749.2005 1:CAS:528:DC%2BD2MXhtVGmur%2FI (Pubitemid 41356248)
13. RM Donlan 2009 Preventing biofilms of clinically relevant organisms using bacteriophage Trends Microbiol 17 66 72 10.1016/j.tim.2008.11.002 1:CAS:528:DC%2BD1MXit1Okt7g%3D
14. F Götz 2002 Staphylococcus and biofilms Mol Microbiol 43 1367 1378 10.1046/j.1365-2958.2002.02827.x (Pubitemid 34595531)
15. GW Hanlon 2007 Bacteriophages: an appraisal of their role in the treatment of bacterial infections Int J Antimicrob Agents 30 118 128 10.1016/j.ijantimicag.2007.04.006 1:CAS:528:DC%2BD2sXntFart74%3D
16. JA Hermoso JL García P García 2007 Taking aim on bacterial pathogens: from phage therapy to enzybiotics Curr Opin Microbiol 10 461 472 10.1016/j.mib.2007.08.002 1:CAS:528:DC%2BD2sXht1yltbzM (Pubitemid 350064581)
17. AP Johnson HM Aucken S Cavendish M Ganner MC Wale M Warner DM Livermore BD Cookson the UK EARSS participants 2001 Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS) J Antimicrob Chemother 48 143 144 10.1093/jac/48.1.143 1:CAS:528:DC%2BD3MXlsVegurg%3D
18. Y Le Loir F Baron M Gautier 2003 Staphylococcus aureus and food poisoning Genet Mol Res 2 63 76
19. JM Loeffler D Nelson VA Fischetti 2001 Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase Science 294 2170 2172 10.1126/science.1066869 1:CAS:528:DC%2BD3MXptVOmsbc%3D (Pubitemid 33150674)
20. MJ Loessner 2005 Bacteriophage endolysins-current state of research and applications Curr Opin Microbiol 8 480 487 10.1016/j.mib.2005.06.002 1:CAS:528:DC%2BD2MXmvVCmsLk%3D (Pubitemid 41021911)
21. G Lu EN Moriyama 2004 Vector NTI, a balanced all-in-one sequence analysis suite Brief Bioinform 5 378 388 10.1093/bib/5.4.378 1:CAS:528: DC%2BD2MXhsVejt7k%3D
22. TF Mah B Pitts B Pellock GC Walker PS Stewart GA O'Toole 2003 A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance Nature 426 306 310 10.1038/nature02122 1:CAS:528:DC%2BD3sXptVOit7w%3D (Pubitemid 37463151)
23. MB Melchior H Vaarkamp J Fink-Gremmels 2006 Biofilms: a role in recurrent mastitis infections? Vet J 171 398 407 10.1016/j.tvjl.2005.01.006 1:CAS:528:DC%2BD28Xjs1Kju7o%3D
24. D Nelson R Schuch S Zhu DM Tscherne VA Fischetti 2003 Genomic sequence of C1, the first streptococcal phage J Bacteriol 185 3325 3332 10.1128/JB.185.11.3325-3332.2003 1:CAS:528:DC%2BD3sXkt1Sgur8%3D (Pubitemid 36617744)
25. RP Novick 1963 Analysis by transduction of mutations affecting penicillinase formation in Staphylococcus aureus J Gen Microbiol 33 121 136 1:CAS:528:DyaF2cXktF2qur0%3D
26. RP Novick 1967 Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus Virology 33 155 166 10.1016/0042-6822(67)90105-5 1:STN:280:DyaF2s3ls1Wgtw%3D%3D
27. S O'Flaherty A Coffey W Meaney GF Fitzgerald RP Ross 2005 The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus J Bacteriol 187 7161 7164 10.1128/JB.187.20.7161-7164.2005 (Pubitemid 41428894)
28. JP O'Gara H Humphreys 2001 Staphylococcus epidermidis biofilms: importance and implications J Med Microbiol 50 581 587
29. P Sass G Bierbaum 2007 Lytic activity of recombinant bacteriophage φ11 and φ12 endolysins on whole cells and biofilms of Staphylococcus aureus Appl Environ Microbiol 73 347 352 10.1128/AEM.01616-06 1:CAS:528:DC%2BD2sXms1Wqsg%3D%3D (Pubitemid 46079972)
30. K Seidl C Goerke C Wolz D Mack B Berger-Bächi M Bischoff 2008 Staphylococcus aureus CcpA affects biofilm formation Infect Immun 76 2044 2050 10.1128/IAI.00035-08 1:CAS:528:DC%2BD1cXltlektbc%3D (Pubitemid 351656137)
31. PS Stewart 2002 Mechanisms of antibiotic resistance in bacterial biofilms Int J Med Microbiol 292 107 113 10.1078/1438-4221-00196 1:CAS:528: DC%2BD38XnsVCqur4%3D
32. M Takác A Witte U Bläsi 2005 Functional analysis of the lysis genes of Staphylococcus aureus phage P68 in Escherichia coli Microbiology 151 2331 2342 10.1099/mic.0.27937-0 (Pubitemid 40984306)
33. Y Tanji T Shimada H Fukudomi K Miyanaga Y Nakai H Unno 2005 Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice J Biosci Bioeng 100 280 287 10.1263/jbb.100.280 1:CAS:528:DC%2BD2MXht1alt7%2FM (Pubitemid 41755292)
34. D Vybiral M Takáč M Loessner A Witte U von Ahsen U Bläsi 2003 Complete nucleotide sequence and molecular characterization of two lytic Staphylococcus aureus phages: 44AHJD and P68 FEMS Microbiol Lett 219 275 283 10.1016/S0378-1097(03)00028-4 1:CAS:528:DC%2BD3sXhs1Kltbw%3D (Pubitemid 36302609)
35. JA Wu C Kusuma JJ Mond JF Kokai-Kun 2003 Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces Antimicrob Agents Chemother 47 3407 3414 10.1128/AAC.47.11.3407-3414. 2003 1:CAS:528:DC%2BD3sXovVaitr0%3D (Pubitemid 37345697)
36. P Yoong R Schuch D Nelson VA Fischetti 2004 Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium J Bacteriol 186 4808 4812 10.1128/JB.186.14.4808-4812.2004 1:CAS:528:DC%2BD2cXmtVemsbk%3D (Pubitemid 38891043)